On the 1st June 2018, Vanessa’s family shared this devastating message:
“It’s with immense sadness that I write this post. This morning, our beautiful daughter Vanessa passed away peacefully at home with Connie, Olivia and I. Vanessa has been such a huge inspiration to many and will continue to live on in our hearts forever.

Vanessa's story

Vanessa, who had beaten neuroblastoma once already, relapsed in December 2011 and was given a less than 10% chance of survival. As there was no relapse protocol for her available in the UK, her parents, Chris and Connie Riddle immediately launched a fundraising appeal with the Neuroblastoma Alliance UK to raise the funds needed to send Vanessa for treatment abroad. They knew this treatment would not be funded by the NHS.

Following further tests and consultations after the relapse, Vanessa has been found to be a good candidate for a treatment in Germany, a Haploidentical Stem Cell transplant, which has shown very promising results. Vanessa hopes to start her treatment in Germany in August 2012; the treatment will take nine months and will dramatically increase her chances of long-term survival.

All the funds raised to date for the Vanessa Riddle Appeal will be used to cover the Haploidentical Stem Cell transplant treatment and associated costs. Any money left over will be kept for Vanessa in case she needs more help in the future.

Vanessa’s Dad, Chris, said: “Words simply cannot express how grateful we are to the kind hearted people who have helped us get to where we are today. From facing a very uncertain future with such a desperately poor prognosis, we are now able to look to the future with optimism.

"Everyone who donated to Vanessa’s Appeal has given us so much more than the money that now makes our daughter’s treatment in Germany a reality. You have given us hope. And for this we thank you from the bottom of our hearts.

"We urge those who have to continue supporting the Neuroblastoma Alliance UK so that the charity can continue their unique and vital work of helping children to get the treatment they need abroad, supporting families and funding research”.